Your browser doesn't support javascript.
loading
Fractal Dimension Analysis in Neurological Disorders: An Overview.
Díaz Beltrán, Leticia; Madan, Christopher R; Finke, Carsten; Krohn, Stephan; Di Ieva, Antonio; Esteban, Francisco J.
Afiliación
  • Díaz Beltrán L; Department of Medical Oncology, Clinical Research Unit, University Hospital of Jaén, Jaén, Spain.
  • Madan CR; School of Psychology, University of Nottingham, Nottingham, UK.
  • Finke C; Department of Neurology, Charité-Universitätsmedizin, Berlin, Germany.
  • Krohn S; Department of Neurology, Charité-Universitätsmedizin, Berlin, Germany.
  • Di Ieva A; Computational NeuroSurgery (CNS) Lab, Faculty of Medicine, Health and Human Sciences, Macquarie Medical School, Macquarie University, Sydney, NSW, Australia.
  • Esteban FJ; Systems Biology Unit, Department of Experimental Biology, University of Jaén, Jaén, Spain. festeban@ujaen.es.
Adv Neurobiol ; 36: 313-328, 2024.
Article en En | MEDLINE | ID: mdl-38468040
ABSTRACT
Fractal analysis has emerged as a powerful tool for characterizing irregular and complex patterns found in the nervous system. This characterization is typically applied by estimating the fractal dimension (FD), a scalar index that describes the topological complexity of the irregular components of the nervous system, both at the macroscopic and microscopic levels, that may be viewed as geometric fractals. Moreover, temporal properties of neurophysiological signals can also be interpreted as dynamic fractals. Given its sensitivity for detecting changes in brain morphology, FD has been explored as a clinically relevant marker of brain damage in several neuropsychiatric conditions as well as in normal and pathological cerebral aging. In this sense, evidence is accumulating for decreases in FD in Alzheimer's disease, frontotemporal dementia, Parkinson's disease, multiple sclerosis, and many other neurological disorders. In addition, it is becoming increasingly clear that fractal analysis in the field of clinical neurology opens the possibility of detecting structural alterations in the early stages of the disease, which highlights FD as a potential diagnostic and prognostic tool in clinical practice.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Demencia Frontotemporal / Enfermedad de Alzheimer Límite: Humans Idioma: En Revista: Adv Neurobiol Año: 2024 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Demencia Frontotemporal / Enfermedad de Alzheimer Límite: Humans Idioma: En Revista: Adv Neurobiol Año: 2024 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos